I know miRNA that targeted a gene in rats and has been proven experimentally. The hsa- miRNA is identical to rno-miRNA, so I decided to quantify this miRNA in a patient's serum instead of a cell line or tissue sample. Is this logical? Should I have experimental evidence or can I rely on it and design a study?

Similar questions and discussions